Results 231 to 240 of about 36,503 (286)

Coexisting Polymorphisms of P2Y12 and CYP2C19 Genes as a Risk Factor for Persistent Platelet Activation With Clopidogrel

, 2008
Łukasz A. Małek, Bartłomiej Kisiel, Mateusz Śpiewak, Marcin Grabowski, Krzysztof J. Filipiak‬, Grażyna Kostrzewa, Zenon Huczek, Rafał Płoski, Grzegorz Opolski   +8 more
openalex   +2 more sources

Molecular Ancestry Across Allelic Variants of <i>SLC22A1</i>, <i>SLC22A2</i>, <i>SLC22A3</i>, <i>ABCB1</i>, <i>CYP2C8</i>, <i>CYP2C9</i>, and <i>CYP2C19</i> in Mexican-Mestizo DMT2 Patients. [PDF]

Biomedicines
Ortega-Ayala A, de la Cruz CG, Dorado P, Rodrigues-Soares F, Castillo-Nájera F, LLerena A, Molina-Guarneros J.   +6 more
europepmc   +1 more source

Pharmacokinetics of the new proton pump inhibitor ilaprazole in Chinese healthy subjects in relation to CYP3A5 and CYP2C19 genotypes

, 2008
Yalin Li, Wei Zhang, Dong Guo, Gan Zhou, Hong‐Hao Zhou, Zhousheng Xiao   +5 more
openalex   +2 more sources

Cardiac myosin inhibitors: a silver lining for an old disease. [PDF]

Open Heart
Yadav S, Agstam S, Singh S.
europepmc   +1 more source

Early effects of Lansoprazole orally disintegrating tablets on intragastric pH in CYP2C19 extensive metabolizers

, 2008
Hatsushi Yamagishi, Tomoyuki Koike, Shuichi Ohara, Toru Horii, Ryousuke Kikuchi, Shigeyuki Kobayashi, Yasuhiko Abe, Katsunori Iijima, Akira Imatani, Kaori Suzuki, Takanori Hishinuma, Junichi Goto, Tooru Shimosegawa   +12 more
openalex   +1 more source

Prevalence of Actionable Exposures to Pharmacogenetic Medications Among Solid Organ Transplant Recipients in a Population-Scale Biobank. [PDF]

J Pers Med
Radwan A, Deininger KM, Ambardekar AV, Anderson HD, Rafaels N, Saba LM, The Colorado Center For Personalized Medicine, Aquilante CL.   +7 more
europepmc   +1 more source

Cataloging Actionable Pharmacogenomic Variants for Indian Clinical Practice: A Scoping Review. [PDF]

J Xenobiot
Kulkarni SS, R V, Das A, Iyer GR.
europepmc   +1 more source

The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome

, 2009
Corinne Frère, Thomas Cuisset, Bénédicte Gaborit, Marie‐Christine Alessi, Jean‐Sébastien Hulot   +4 more
openalex   +1 more source

Frequency and Implications of High-Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort. [PDF]

Clin Transl Sci
Moore C, Halman A, Stenta T, Khatri D, Williams E, Dyas R, Stolper J, Elliott DA, Conyers R.   +8 more
europepmc   +1 more source

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease

, 2009
Christoph Varenhorst, Stefan James, David Erlinge, John T. Brandt, Oscar Ö. Braun, M. Man, Agneta Siegbahn, Judith S. Walker, Lars Wallentin, Kenneth J. Winters, Sandra Close   +10 more
openalex   +1 more source